Chronic Hand Eczema. Other atopic dermatitis
Conditions
Interventions
Intervention 1: Intervention group: the patients receive topical curcumin made by Exir Nano Sina Company of Iran. the patients will apply the medication twice daily for eight weeks on the affected are
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients above ?? years of age with chronic hand eczema who have not received topical or oral treatments for this condition in the past two weeks consent to participate in the study
Exclusion criteria
Exclusion criteria: patients younger than ?? years old pregnancy breastfeeding having underlying disease in need of systemic corticosteroids such as adrenal insufficiency and rheumatologic disease using topical or oral immunomodulators chronic kidney disease hepatic insufficiency the need for more potent corticosteroids (such as clobetasol) unwillingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of chronic hand eczema. Timepoint: 8 weeks after treatment initiation. Method of measurement: Hand Eczema Severity Index (HECSI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects of topical curcumin. Timepoint: 8 weeks from initiation of therapy. Method of measurement: interview and physical examination.;Quality of lfe. Timepoint: 8 weeks from initiation of therapy. Method of measurement: Dermatologic Life Quality Index (DLQI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Khajavi
Shiraz University of Medical Sciences
Outcome results
None listed